Lv2
168 积分 2025-01-21 加入
[Daratumumab for the treatment of primary systemic amyloidosis: a multicenter retrospective analysis]
8天前
已完结
Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria
9天前
已完结
Kidney and liver involvement in monoclonal light chain disorders
1个月前
已完结
Nail Involvement as an Early Manifestation of Systemic Light‐Chain Amyloidosis
1个月前
已完结
Hepatic Response Dynamics in Newly Diagnosed Patients with Light-chain Amyloidosis: A Retrospective Cohort Study
3个月前
已关闭
Factors associated with changes in serum transthyretin after treatment with tafamidis and outcomes in transthyretin cardiac amyloidosis
4个月前
已完结
Hepatic Response and Progression Criteria in Light Chain Amyloidosis: A Multicenter Validation Study
4个月前
已完结
Clinical presentation and prognostic analysis of Chinese patients with systemic light chain amyloidosis with liver involvement
5个月前
已完结
Hepatic Response and Progression Criteria in Light Chain Amyloidosis: A Multicenter Validation Study
7个月前
已关闭
Daratumumab: A Review in Newly Diagnosed Systemic Light Chain Amyloidosis
7个月前
已完结
皖公网安备34019202002308